PLSE
Pulse Biosciences, Inc.
Price Chart
Latest Quote
$25.68
+0.08 (+0.31%)
Current Price
| Previous Close | $25.60 |
| Open | $25.42 |
| Day High | $26.23 |
| Day Low | $25.20 |
| Volume | 33,528 |
Stock Information
| Shares Outstanding | 69.21M |
| Total Debt | $7.16M |
| Cash Equivalents | $68.32M |
| Revenue | $751K |
| Net Income | $-74.57M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.78B |
| EPS (TTM) | $-1.10 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.71B |
| Sales | $751K |
| Income | $-74.57M |
| Book/sh | $0.97 |
| Cash/sh | $0.99 |
| Employees | 116 |
Financial Ratios
| Quick Ratio | 6.99 |
| Current Ratio | 7.26 |
| Debt/Eq | 10.79 |
Returns & Margins
| ROA | -45.03% |
| ROE | -80.72% |
| Gross Margin | -21.04% |
| Operating Margin | -4775.56% |
Ownership
| Insider Ownership | 73.38% |
| Institutional Ownership | 11.56% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -23.56 |
| P/S | 2366.59 |
| P/B | 26.42 |
Analyst Data
| Recommendation | none |
| Target Price | $30.67 |
Technical Indicators
| SMA20 | $25.36 |
| SMA50 | $23.43 |
| SMA200 | $18.67 |
| RSI | 53.55 |
| ATR | 1.8756 |
| Shares Float | 18.34M |
| Short Float | 16.06% |
| Short Ratio | 8.20 |
| Volatility | 1.66 |
| Rel Volume | 0.12 |
Performance History
| Week | +5.38% |
| Month | -1.57% |
| Quarter | +16.20% |
| 6 Months | +80.08% |
| YTD | +91.78% |
| Year | +70.63% |
| 3 Years | +290.27% |
| 5 Years | +44.51% |
| 10 Years | +500.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $25.68 | 33,528 |
| 2026-06-18 | $25.60 | 364,300 |
| 2026-06-17 | $25.45 | 196,700 |
| 2026-06-16 | $25.11 | 271,900 |
| 2026-06-15 | $25.92 | 362,800 |
| 2026-06-12 | $24.37 | 403,300 |
| 2026-06-11 | $26.89 | 450,600 |
| 2026-06-10 | $24.99 | 299,700 |
| 2026-06-09 | $25.77 | 218,600 |
| 2026-06-08 | $24.84 | 242,300 |
| 2026-06-05 | $25.33 | 315,300 |
| 2026-06-04 | $26.94 | 640,700 |
| 2026-06-03 | $24.99 | 261,500 |
| 2026-06-02 | $24.28 | 230,300 |
| 2026-06-01 | $24.67 | 202,800 |
| 2026-05-29 | $25.00 | 268,600 |
| 2026-05-28 | $24.74 | 243,300 |
| 2026-05-27 | $24.72 | 303,300 |
| 2026-05-26 | $26.00 | 185,200 |
| 2026-05-22 | $25.89 | 250,600 |
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
đ° Latest News
Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?
Simply Wall St. âĸ 2026-06-09T11:08:12Z
Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy
Zacks âĸ 2026-05-26T16:00:01Z
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
Motley Fool âĸ 2026-05-17T15:02:01Z
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?
Simply Wall St. âĸ 2026-05-10T16:08:01Z
Pulse Biosciences Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T20:05:36Z
PLSE Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T14:18:53Z
Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2026-05-07T16:00:04Z
PLSE Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-05-04T20:32:49Z
Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-04T12:05:03Z
Pulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation Story
Simply Wall St. âĸ 2026-04-23T08:06:31Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $539,000 | $0 | $0 | $11,944,000 |
| Cost Of Revenue | $539,000 | $0 | $0 | $11,944,000 |
| Total Revenue | $350,000 | $0 | $0 | $700,000 |
| Operating Revenue | $350,000 | $0 | $0 | $700,000 |
| Expenses | ||||
| Total Expenses | $77,289,000 | $56,257,000 | $43,574,000 | $58,757,000 |
| Other Income Expense | $-52,000 | $-18,000 | - | - |
| Other Non Operating Income Expenses | $-52,000 | $-18,000 | - | - |
| Net Non Operating Interest Income Expense | $4,210,000 | $2,690,000 | $1,364,000 | $-448,000 |
| Operating Expense | $76,750,000 | $56,257,000 | $43,574,000 | $46,813,000 |
| Total Other Finance Cost | - | $-2,672,000 | $-1,364,000 | $448,000 |
| General And Administrative Expense | - | $23,921,000 | $15,777,000 | $13,955,000 |
| Selling And Marketing Expense | - | - | $0 | $12,019,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Net Interest Income | $4,210,000 | $2,690,000 | $1,364,000 | $-448,000 |
| Interest Income | $4,210,000 | $2,690,000 | - | - |
| Normalized Income | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Net Income From Continuing And Discontinued Operation | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Total Operating Income As Reported | $-76,939,000 | $-56,257,000 | $-43,574,000 | $-58,057,000 |
| Net Income Common Stockholders | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Net Income | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Net Income Including Noncontrolling Interests | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Net Income Continuous Operations | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Pretax Income | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Interest Income Non Operating | $4,210,000 | $2,690,000 | - | - |
| Operating Income | $-76,939,000 | $-56,257,000 | $-43,574,000 | $-58,057,000 |
| Gross Profit | $-189,000 | $0 | $0 | $-11,244,000 |
| Per Share | ||||
| Diluted EPS | $-1.08 | $-0.92 | $-0.85 | $-1.69 |
| Basic EPS | $-1.08 | $-0.92 | $-0.85 | $-1.69 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-75,868,000 | $-55,079,000 | $-42,367,000 | $-56,702,000 |
| Reconciled Depreciation | $1,071,000 | $1,178,000 | $1,207,000 | $1,355,000 |
| EBITDA (Bullshit earnings) | $-75,868,000 | $-55,079,000 | $-42,367,000 | $-56,702,000 |
| EBIT | $-76,939,000 | $-56,257,000 | $-43,574,000 | $-58,057,000 |
| Diluted Average Shares | $67,395,339 | $58,398,000 | $49,737,000 | $34,510,336 |
| Basic Average Shares | $67,395,339 | $58,398,000 | $49,737,000 | $34,510,336 |
| Diluted NI Availto Com Stockholders | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Research And Development | $44,721,000 | $32,336,000 | $27,797,000 | $20,839,000 |
| Selling General And Administration | $32,029,000 | $23,921,000 | $15,777,000 | $25,974,000 |
| Tax Provision | - | $0 | $0 | $0 |
| Other Gand A | - | $23,921,000 | $15,777,000 | $13,955,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $77,290,000 | $110,851,000 | $39,683,000 | $-7,590,000 |
| Total Assets | $94,539,000 | $132,460,000 | $59,154,000 | $77,877,000 |
| Total Non Current Assets | $11,118,000 | $13,011,000 | $13,826,000 | $15,730,000 |
| Other Non Current Assets | $691,000 | $677,000 | $365,000 | $365,000 |
| Goodwill And Other Intangible Assets | $3,366,000 | $4,011,000 | $4,677,000 | $5,342,000 |
| Other Intangible Assets | $575,000 | $1,220,000 | $1,886,000 | $2,551,000 |
| Current Assets | $83,421,000 | $119,449,000 | $45,328,000 | $62,147,000 |
| Other Current Assets | $2,276,000 | $1,411,000 | $963,000 | $1,008,000 |
| Inventory | $136,000 | $0 | - | $0 |
| Receivables | $274,000 | $0 | - | $0 |
| Accounts Receivable | $274,000 | $0 | - | $0 |
| Cash Cash Equivalents And Short Term Investments | $80,735,000 | $118,038,000 | $44,365,000 | $61,139,000 |
| Cash And Cash Equivalents | $80,735,000 | $118,038,000 | $44,365,000 | $61,139,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $7,530,000 | $8,898,000 | $9,144,000 | $75,957,000 |
| Long Term Debt And Capital Lease Obligation | $5,960,000 | $7,543,000 | $8,086,000 | $74,144,000 |
| Current Debt And Capital Lease Obligation | $1,570,000 | $1,355,000 | $1,058,000 | $1,813,000 |
| Net Debt | - | - | - | $4,778,000 |
| Long Term Debt | - | - | - | $65,000,000 |
| Current Debt | - | - | - | $917,000 |
| Other Current Borrowings | - | - | - | $917,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $13,883,000 | $17,598,000 | $14,794,000 | $80,125,000 |
| Total Non Current Liabilities Net Minority Interest | $5,960,000 | $7,543,000 | $8,086,000 | $74,144,000 |
| Current Liabilities | $7,923,000 | $10,055,000 | $6,708,000 | $5,981,000 |
| Payables And Accrued Expenses | $4,374,000 | $3,905,000 | $2,451,000 | $2,791,000 |
| Payables | $2,777,000 | $1,673,000 | $1,836,000 | $1,573,000 |
| Accounts Payable | $2,777,000 | $1,673,000 | $1,836,000 | $1,573,000 |
| Current Deferred Liabilities | - | - | - | $0 |
| Current Notes Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $80,656,000 | $114,862,000 | $44,360,000 | $-2,248,000 |
| Total Equity Gross Minority Interest | $80,656,000 | $114,862,000 | $44,360,000 | $-2,248,000 |
| Stockholders Equity | $80,656,000 | $114,862,000 | $44,360,000 | $-2,248,000 |
| Retained Earnings | $-463,281,000 | $-390,500,000 | $-336,915,000 | $-294,705,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $0 | $0 |
| Other | ||||
| Ordinary Shares Number | $67,839,689 | $65,926,000 | $56,078,915 | $37,866,284 |
| Share Issued | $67,839,689 | $65,926,000 | $56,078,915 | $37,866,284 |
| Tangible Book Value | $77,290,000 | $110,851,000 | $39,683,000 | $-7,590,000 |
| Invested Capital | $80,656,000 | $114,862,000 | $44,360,000 | $63,669,000 |
| Working Capital | $75,498,000 | $109,394,000 | $38,620,000 | $56,166,000 |
| Capital Lease Obligations | $7,530,000 | $8,898,000 | $9,144,000 | $10,040,000 |
| Total Capitalization | $80,656,000 | $114,862,000 | $44,360,000 | $62,752,000 |
| Additional Paid In Capital | $543,869,000 | $505,296,000 | $381,220,000 | $292,420,000 |
| Capital Stock | $68,000 | $66,000 | $55,000 | $37,000 |
| Common Stock | $68,000 | $66,000 | $55,000 | $37,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $5,960,000 | $7,543,000 | $8,086,000 | $9,144,000 |
| Current Capital Lease Obligation | $1,570,000 | $1,355,000 | $1,058,000 | $896,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,979,000 | $4,795,000 | $3,199,000 | $1,377,000 |
| Current Accrued Expenses | $1,597,000 | $2,232,000 | $615,000 | $1,218,000 |
| Goodwill | $2,791,000 | $2,791,000 | $2,791,000 | $2,791,000 |
| Net PPE | $7,061,000 | $8,323,000 | $8,784,000 | $10,023,000 |
| Accumulated Depreciation | $-4,374,000 | $-3,968,000 | $-3,476,000 | $-2,953,000 |
| Gross PPE | $11,435,000 | $12,291,000 | $12,260,000 | $12,976,000 |
| Leases | $2,519,000 | $2,519,000 | $2,519,000 | $2,519,000 |
| Construction In Progress | $9,000 | $29,000 | $0 | $22,000 |
| Other Properties | $7,642,000 | $8,505,000 | $8,503,000 | $9,180,000 |
| Machinery Furniture Equipment | $1,265,000 | $1,238,000 | $1,238,000 | $1,255,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Current Deferred Revenue | - | - | - | $0 |
| Finished Goods | - | - | - | $0 |
| Work In Process | - | - | - | $0 |
| Raw Materials | - | - | - | $0 |
| Current Provisions | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-54,457,000 | $-36,468,000 | $-33,162,000 | $-47,414,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-54,122,000 | $-36,343,000 | $-33,041,000 | $-47,013,000 |
| Cash Flow From Continuing Operating Activities | $-54,122,000 | $-36,343,000 | $-33,041,000 | $-47,013,000 |
| Operating Gains Losses | - | $6,000 | $13,000 | $185,000 |
| Investing Activities | ||||
| Capital Expenditure | $-335,000 | $-125,000 | $-121,000 | $-401,000 |
| Investing Cash Flow | $-335,000 | $-125,000 | $-121,000 | $-401,000 |
| Cash Flow From Continuing Investing Activities | $-335,000 | $-125,000 | $-121,000 | $-401,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $59,649,000 | $0 | $14,864,000 |
| Financing Cash Flow | $17,154,000 | $110,141,000 | $16,388,000 | $79,939,000 |
| Cash Flow From Continuing Financing Activities | $17,154,000 | $110,141,000 | $16,388,000 | $79,939,000 |
| Net Common Stock Issuance | $0 | $59,649,000 | $0 | $14,864,000 |
| Common Stock Issuance | $0 | $59,649,000 | $0 | $14,864,000 |
| Net Other Financing Charges | - | $-281,000 | $-6,000 | $-437,000 |
| Other | ||||
| End Cash Position | $80,735,000 | $118,038,000 | $44,365,000 | $61,139,000 |
| Beginning Cash Position | $118,038,000 | $44,365,000 | $61,139,000 | $28,614,000 |
| Changes In Cash | $-37,303,000 | $73,673,000 | $-16,774,000 | $32,525,000 |
| Proceeds From Stock Option Exercised | $17,154,000 | $50,773,000 | $16,394,000 | $512,000 |
| Net Intangibles Purchase And Sale | $-20,000 | $0 | - | - |
| Purchase Of Intangibles | $-20,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-315,000 | $-125,000 | $-121,000 | $-401,000 |
| Purchase Of PPE | $-315,000 | $-125,000 | $-121,000 | $-401,000 |
| Change In Working Capital | $-5,022,000 | $1,549,000 | $768,000 | $-3,716,000 |
| Change In Other Current Liabilities | $-1,368,000 | $-1,076,000 | $-896,000 | $-774,000 |
| Change In Other Current Assets | $-14,000 | $-31,000 | $806,000 | $723,000 |
| Change In Payables And Accrued Expense | $-2,318,000 | $3,011,000 | $814,000 | $-2,180,000 |
| Change In Accrued Expense | $-3,450,000 | $3,212,000 | $551,000 | $-876,000 |
| Change In Payable | $1,132,000 | $-201,000 | $263,000 | $-1,304,000 |
| Change In Account Payable | $1,132,000 | $-201,000 | $263,000 | $-1,304,000 |
| Change In Prepaid Assets | $-912,000 | $-355,000 | $-65,000 | $1,164,000 |
| Change In Inventory | $-136,000 | $0 | $0 | $-2,653,000 |
| Change In Receivables | $-274,000 | $0 | $109,000 | $20,000 |
| Changes In Account Receivables | $-274,000 | $0 | $0 | $61,000 |
| Other Non Cash Items | $1,153,000 | $923,000 | - | - |
| Stock Based Compensation | $21,457,000 | $13,586,000 | $7,181,000 | $5,191,000 |
| Depreciation Amortization Depletion | $1,071,000 | $1,178,000 | $1,207,000 | $1,355,000 |
| Depreciation And Amortization | $1,071,000 | $1,178,000 | $1,207,000 | $1,355,000 |
| Amortization Cash Flow | $665,000 | $666,000 | $665,000 | $665,000 |
| Amortization Of Intangibles | $665,000 | $666,000 | $665,000 | $665,000 |
| Depreciation | $406,000 | $512,000 | $542,000 | $690,000 |
| Gain Loss On Sale Of PPE | $0 | $6,000 | $13,000 | $185,000 |
| Net Income From Continuing Operations | $-72,781,000 | $-53,585,000 | $-42,210,000 | $-58,505,000 |
| Change In Interest Payable | - | $0 | $-668,000 | $918,000 |
| Issuance Of Debt | - | - | $0 | $65,000,000 |
| Net Issuance Payments Of Debt | - | - | $0 | $65,000,000 |
| Net Long Term Debt Issuance | - | - | $0 | $65,000,000 |
| Long Term Debt Issuance | - | - | $0 | $65,000,000 |
| Asset Impairment Charge | - | - | $0 | $8,477,000 |
| Repayment Of Debt | - | - | - | $-437,000 |
| Net Short Term Debt Issuance | - | - | - | $64,563,000 |
| Short Term Debt Payments | - | - | - | $-437,000 |
| Short Term Debt Issuance | - | - | - | $65,000,000 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $-16,000 |
| Amortization Of Securities | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | - |
Fetched: 2026-06-18